Company Overview and News
Having been preoccupied with President Trump and the Korean crisis, my writing has slowed down and that's fine. I feel it's best to write when I have something to say or a point to make. Today I have a point to make... thus I write.
Nestle SA has settled a lawsuit in which Atari SA accused the Swiss food company of using the hit 1970s video game "Breakout" without permission to sell Kit Kat bars.
(Reuters) - Nestle SA (NESN.S) has settled a lawsuit in which Atari SA (ATAR.PA) accused the Swiss food company of using the hit 1970s video game “Breakout” without permission to sell Kit Kat bars.
SAN FRANCISCO (Reuters) - A veteran Sony and Microsoft video game executive has joined the hardware development unit at Alphabet Inc’s Google, and analysts said he could help the company hone its efforts in mixed-reality technologies.
A veteran Sony and Microsoft video game executive has joined the hardware development unit at Alphabet Inc's Google, and analysts said he could help the company hone its efforts in mixed-reality technologies.
SAN FRANCISCO, Jan 23 (Reuters) - A veteran Sony and Microsoft video game executive has joined the hardware development unit at Alphabet Inc’s Google, and analysts said he could help the company hone its efforts in mixed-reality technologies.
Ah Atari (EPA: ATA) - the system that many of us "older hands" played as children. While youth of this era might look at Atari and think of it as "primitive" with its one iconic button and basic game play, they would have to warp back in time to really understand just how epic it was. Imagine a world (if you will), void of cell phones, cordless phones, Internet for the common man, absent of VCRs or DVD players.
An apartment building with a video game theme — and a nod to Sunnyvale tech history — has been sold to a private investor for $15.7 million, according to its former owners.
Nestle SA on Friday paddled back claims in a new lawsuit in which Atari SA accused the Swiss food company of pilfering its classic 1970s video game "Breakout" to help sell Kit Kat chocolate-covered wafer bars.
(Reuters) - Nestle SA on Friday paddled back claims in a new lawsuit in which Atari SA accused the Swiss food company of pilfering its classic 1970s video game "Breakout" to help sell Kit Kat chocolate-covered wafer bars.
BARCELONA, España, 2 de marzo de 2017 /PRNewswire/ -- En el Mobile World Congress, FMTwoGame Inc anunció hoy una nueva edición de su gama de smartwatches: 'Gameband DROID Edition'. Esta edición premium de smartwatch se ha creado como respuesta directa a la demanda de respaldo hacia Kickstarter (donde la compañía triplicó su objetivo de fondos a las dos semanas). La DROID Edition incluye el procesador Qualcomm Snapdragon Wear 2100 1.
On Monday September 22, uWink (NASDAQ: UWKI.OB) announced their second software licensing deal to install 4 of their touch-screen terminals in a Chili’s Too Margarita Bar at the Fort Lauderdale Hollywood International Airport as a pilot program for possible expansion into many more locations.
uWink (Nasdaq: UWKI.OB), an entertainment and hospitality software development company and the operator of an interactive restaurant concept called uWink, has made it official and has sent notice that they are opening their latest location at Hollywood and Highland June 27th, 2008.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...